Refine by
Applications
- Clinical Immunology and Intensive Care Medicine for Haemophilia
- Clinical Immunology and Intensive Care Medicine for Immunoglobulins
- Clinical Immunology and Intensive Care Medicine for Antibody Deficiency
- Microbiome Therapeutics for Clinical Trials
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Nuclear Medicine for Therapy
- Nuclear Medicine for Theragnostics
Drug Analysis And Development Equipment & Supplies
2,216 equipment items found
Manufactured by:Synecco Ltd based inGalway, IRELAND
Synecco’s customer tasked us with developing a means of adding value to their generic drug offering. Synecco developed the PharmaTel device in conjunction with NUIG. At the core of the device is a film with a printed circuit that records individual blister cell breaches. The blister plugs into a smart lid which displays key data locally as well as transmitting it to a secure network. ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
PROTAC-Proteolysis targeting chimera is a technology that induces the Ubiquitin-Proteasome System (UPS) to degrade the target protein. When the target protein (Protein of Interest (POI)) is ubiquitinated by the ligase of E1, E2, E3, the proteasome recognizes that part of the protein and degrades the protein. PROTAC is composed of a protein of interest, a ligand that binds to the E3 ligase, and ...
Manufactured by:Locus Biosciences, Inc. based inMorrisville, NORTH CAROLINA (USA)
Locus uses proprietary informatics algorithms and machine learning to further automate Discovery processes and provide data-informed predictions across the company. We can develop models that allow us to better understand variables we haven’t measured yet. Combining genomic and functional datasets enable us to understand how certain organisms may interact with one another. Leveraging data ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Agonist refers to substances that activate a specific target protein. It can easily be viewed as the opposite of inhibitor. Until now, Deargen's drug-target interaction (DTI) was predicted based on the binding affinity between the substance and the target protein, which causes barrier to distinguish between the inhibition and activation activity. In addition, the demand for agonist hit discovery ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...
by:CrystalsFirst GmbH based inMarburg, GERMANY
X-ray crystallography is a strong method for studying biomolecules’ 3D structure. Data gathering technologies for synchrotron radiation have improved, making this approach even more effective and efficient. The crystal is exposed to an intense stream of X-rays for getting high-resolution structural information. The protein crystals deflect these X-rays, resulting in dispersed beams and a ...
Manufactured by:Inoviem Scientific SAS based inIllkirch-Graffenstaden, FRANCE
Identify a cohort of patients responding to your therapy with PIMS® technology; PIMS is a label-free technology based on the dynamic molecular resonance of proteins and ...
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
The drug candidate GS-659, which is sprung from Gesynta Pharma’s drug development platform, is currently in preclinical development phase. Project updates will be announced in due ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Abaloparatide is a parathyroid hormone-related protein (PTHrP) analog drug in clinical development for treating osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent.https://www.creative-peptides.com/product/abaloparatide-item-10-101-172-33658.html ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Full visibility and automated control. Extend your clinical trial command and control center with Suvoda’s integrated ...
Manufactured by:SHL Medical AG based inZug, SWITZERLAND
The development of the Precision Pen Injector (PPI) is a story of uncompromising dedication to meeting industry challenges. A Swedish company specializing in solutions for aesthetics and corrective treatment sought to introduce an autoinjector for its skin booster – a highly viscous hyaluronic acid formulation of several hundred centipoise. The company needed a device that could deliver ...
Manufactured by:PeptaNova GmbH based inSandhausen, GERMANY
1-Deoxyfructosyl-Gly, also known as N-(1-Deoxy-D-fructos-1-yl)-glycine, is a synthetic compound categorized under carbohydrates and conjugate products. It represents a class of Amadori compounds, which are pivotal in biochemical research due to their role in glycation processes. These compounds form through the non-enzymatic reaction of sugars with amino acids, providing insights into the ...
by:KoBioLabs based inGwanak-ro, Gwanak-gu, SOUTH KOREA
New Drug Development Focusing on Immune/Metabolic/Neurological. ...
by:STALICLA based inGeneve, SWITZERLAND
DDU validates ASD phenotype groups and drug candidates through observational studies and investigational trials. DDU combines expertise in operations, medicine, drug and clinical development, to bring STALICLA’s clinical-stage treatment options closer to ...
Manufactured by:ProImmune Ltd. based inOxford, UNITED KINGDOM
Anti-Idiotype Ankyrons a game-changer for developing assays to track target-specific antibodies. Take the pain out of targeting the idiotype of your antibodies. Detecting and targeting specific antibody idiotypes is key for developing effective tracking assays for drug antibodies. Developing monoclonal and eventually recombinant anti-drug idiotype antibodies for such purposes has been possible ...
Manufactured by:Hunan Aslsen Technology Co., Ltd based inFurong District, CHINA
Name: BMK Glycidic Acid CAS 5449-12-7 Purity: 99% Type: Pharmaceutical Intermediates Appearance: White Powder Function: Pharmaceutical Intermediates: BMK Ethyl Glycidate is commonly used as an intermediate in drug synthesis for the preparation of precursors or active ingredients of some drugs. In the pharmaceutical field, organic synthesis intermediates are essential for drug development. Flavor ...
Manufactured by:Hunan Aslsen Technology Co., Ltd based inFurong District, CHINA
Name: BMK Ethyl Glycidate CAS 41232-97-7 Purity: 99% Type: Pharmaceutical Intermediates Appearance: Yellow Liquid; White Powder Function: Pharmaceutical Intermediates: BMK Ethyl Glycidate is commonly used as an intermediate in drug synthesis for the preparation of precursors or active ingredients of some drugs. In the pharmaceutical field, organic synthesis intermediates are essential for drug ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
Our license agreement with Indivior provides for a funded research program, under which we have the right to select drug candidates for exclusive development in certain indications outside of SUD. We plan to develop our selected drug candidates in CMT1a, chronic cough and pain. These indications have been validated with baclofen, an orthosteric agonist of GABAB and present a significant unmet ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Aryl fluorinated building blocks refer to a series of aromatic compounds possessing one or several fluorine atoms directly attached to the aromatic ring skeleton. Fluorine can provide many beneficial properties when incorporated into an Aryl. Firstly, fluorinated arenes are more lipophilic than their non-fluorinated counterparts, which can be used to advantage in drug development. Furthermore, ...
Manufactured by:Troikaa Pharmaceuticals Ltd. based inAhmedabad, INDIA
To provide therapeutically meaningful extended delivery of drugs, Troikaa has developed Duo Phase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus drug delivery is biphasic and ensures the requisite pharmacokinetic profile. Drugs developed ...